[HTML][HTML] Triple-negative breast cancer: current understanding and future therapeutic breakthrough targeting cancer stemness
KL Lee, YC Kuo, YS Ho, YH Huang - Cancers, 2019 - mdpi.com
Triple-negative breast cancer (TNBC) is cancer that tested as negative for estrogen
receptors (ER), progesterone receptors (PR), and excess human epidermal growth factor …
receptors (ER), progesterone receptors (PR), and excess human epidermal growth factor …
[HTML][HTML] Triple-Negative Breast Cancer: Current Understanding and Future Therapeutic Breakthrough Targeting Cancer Stemness
KL Lee, YC Kuo, YS Ho, YH Huang - Cancers, 2019 - ncbi.nlm.nih.gov
Triple-negative breast cancer (TNBC) is cancer that tested as negative for estrogen
receptors (ER), progesterone receptors (PR), and excess human epidermal growth factor …
receptors (ER), progesterone receptors (PR), and excess human epidermal growth factor …
Triple-Negative Breast Cancer: Current Understanding and Future Therapeutic Breakthrough Targeting Cancer Stemness.
KL Lee, YC Kuo, YS Ho, YH Huang - Cancers, 2019 - europepmc.org
Triple-negative breast cancer (TNBC) is cancer that tested as negative for estrogen
receptors (ER), progesterone receptors (PR), and excess human epidermal growth factor …
receptors (ER), progesterone receptors (PR), and excess human epidermal growth factor …
Triple-Negative Breast Cancer: Current Understanding and Future Therapeutic Breakthrough Targeting Cancer Stemness.
KL Lee, YC Kuo, YS Ho, YH Huang - Cancers, 2019 - search.ebscohost.com
Triple-negative breast cancer (TNBC) is cancer that tested as negative for estrogen
receptors (ER), progesterone receptors (PR), and excess human epidermal growth factor …
receptors (ER), progesterone receptors (PR), and excess human epidermal growth factor …
Triple-Negative Breast Cancer: Current Understanding and Future Therapeutic Breakthrough Targeting Cancer Stemness
L Kha-Liang, YC Kuo, H Yuan-Soon, H Yen-Hua - Cancers, 2019 - search.proquest.com
Triple-negative breast cancer (TNBC) is cancer that tested as negative for estrogen
receptors (ER), progesterone receptors (PR), and excess human epidermal growth factor …
receptors (ER), progesterone receptors (PR), and excess human epidermal growth factor …
Triple-negative breast cancer: Current understanding and future therapeutic breakthrough targeting cancer stemness
KL Lee, YC Kuo, YS Ho, YH Huang - Cancers, 2019 - hub.tmu.edu.tw
摘要Triple-negative breast cancer (TNBC) is cancer that tested as negative for estrogen
receptors (ER), progesterone receptors (PR), and excess human epidermal growth factor …
receptors (ER), progesterone receptors (PR), and excess human epidermal growth factor …
[PDF][PDF] Triple-Negative Breast Cancer: Current Understanding and Future Therapeutic Breakthrough Targeting Cancer Stemness
KL Lee, YC Kuo, YS Ho - pdfs.semanticscholar.org
Triple-negative breast cancer (TNBC) is cancer that tested as negative for estrogen
receptors (ER), progesterone receptors (PR), and excess human epidermal growth factor …
receptors (ER), progesterone receptors (PR), and excess human epidermal growth factor …
Triple-Negative Breast Cancer: Current Understanding and Future Therapeutic Breakthrough Targeting Cancer Stemness
KL Lee, YC Kuo, YS Ho, YH Huang - Cancers, 2019 - cir.nii.ac.jp
抄録< jats: p> Triple-negative breast cancer (TNBC) is cancer that tested as negative for
estrogen receptors (ER), progesterone receptors (PR), and excess human epidermal growth …
estrogen receptors (ER), progesterone receptors (PR), and excess human epidermal growth …
Triple-Negative Breast Cancer: Current Understanding and Future Therapeutic Breakthrough Targeting Cancer Stemness
KL Lee, YC Kuo, YS Ho, YH Huang - Cancers, 2019 - pubmed.ncbi.nlm.nih.gov
Triple-negative breast cancer (TNBC) is cancer that tested as negative for estrogen
receptors (ER), progesterone receptors (PR), and excess human epidermal growth factor …
receptors (ER), progesterone receptors (PR), and excess human epidermal growth factor …
Triple-negative breast cancer: Current understanding and future therapeutic breakthrough targeting cancer stemness
KL Lee, YC Kuo, YS Ho, YH Huang - Cancers, 2019 - hub.tmu.edu.tw
Triple-negative breast cancer (TNBC) is cancer that tested as negative for estrogen
receptors (ER), progesterone receptors (PR), and excess human epidermal growth factor …
receptors (ER), progesterone receptors (PR), and excess human epidermal growth factor …